A colorectal specialist at OU Cancer Institute is offering transanal endoscopic microsurgery as a treatment for colorectal cancer, according to a news release. Gary Dunn, MD, has incorporated the ...
Phase II study of TAS-OX (TAS-102 and oxaliplatin) plus bevacizumab for late-line colorectal cancer. Cox regression analysis of recurrence-free survival.
The development of complete personalized treatment plans for colon cancer patients utilizing three gene prediction models. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This ...
Colorectal Mucinous Cancers Are a Distinct Genetic Subtype New data show that the relatively rare mucinous carcinomas are genetically different from nonmucinous cancers and represent a distinct ...